dr. polsky on the predictive value of ctdna in braf-mutant melanoma
Published 5 years ago • 55 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
1:02
dr. polsky on the clinical validity of ctdna in braf-mutant melanoma
-
1:22
dr. polsky on validating ctdna as a biomarker in braf-mutant melanoma
-
0:57
dr. polsky on potential applications of ctdna in melanoma
-
1:12
dr. polsky on the association between ctdna and survival in melanoma
-
1:13
dr. polsky on using ctdna as a biomarker for melanoma
-
20:34
role of circulating tumor cells/dna & liquid biopsy in melanoma - david polsky
-
0:55
dr. polsky on the unmet need of clinical utility in liquid biopsy
-
0:49
dr. polsky on the exploration of blood-based biomarkers in melanoma
-
2:03
analysis demonstrates correlation between presence of ctdna and survival in melanoma
-
1:32
dr. pavlick on sequencing challenges with braf-mutant melanoma
-
0:59
how physicians can detect ctdna in melanoma
-
1:46
dr. long on the results of the pooled analysis of the combi-i trial in melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
2:26
dr. goetz on the use of ctdna in the monarch-3 trial in hr /her2- breast cancer
-
1:26
dr. nathan on long-term outcomes with dabrafenib/trametinib in braf v600-mutant melanoma
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:44
ctdna measurement via liquid biopsies in cancer of unknown primary
-
0:25
daniel p. petrylak, md, on the role of dna repair gene mutations in metastatic urothelial carcinoma
-
9:03
prognostic/predictive value of tumor-sidedness in crc